Electrophoresis Market Research Report Information By Product (Electrophoresis Reagents, Electrophoresis Systems, Gel Documentation Systems, Electrophoresis Software), By Application (Research Application, Diagnostic Applications, and Quality Control & Process Validation), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Diagnostic Centers), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Global Electrophoresis Market Overview

The Electrophoresis Market was valued at USD 3.2 billion in 2022. The Electrophoresis market industry is projected to grow from USD 3.38 billion in 2023 to USD 5.36 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.90% during the forecast period (2024 - 2032). Increasing demand for personalized medicine and rising applications in proteomics and genomics research are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Electrophoresis Market Trends

• Growing advances in the proteomics sector are driving market growth

Considerable advances in biotechnology and proteomics research are driving the electrophoresis market. As researchers delve further into understanding disease mechanisms and discovering new treatment targets, the demand for advanced electrophoresis techniques has increased. Electrophoresis is an important tool for separating and studying proteins, nucleic acids, and other biomolecules, allowing researchers to understand complex biological processes. Scientists may now obtain improved resolution and sensitivity using high-throughput electrophoresis equipment and new gel matrices, which is pushing the usage of electrophoresis in a variety of scientific applications.

The rising frequency of chronic diseases like cancer, diabetes, cardiovascular disorders, and genetic disorders emphasizes the need for precise diagnostic tools and methodologies. Electrophoresis is a reliable approach for detecting biomarkers linked with various illnesses, which can aid in early diagnosis, prognosis, and individualized treatment regimens. Furthermore, as the global population ages and lifestyle factors lead to an increase in chronic illnesses, there is a growing need for better diagnostic solutions, which drives demand for electrophoresis systems and consumables.

Another major factor driving the electrophoresis Market CAGR is the shift toward customized medicine and pharmacogenomics. With advances in genomic technologies and a better understanding of how genetic differences affect drug reactions, there is a shift toward personalizing medical therapies to individual genetic profiles. Electrophoresis techniques, such as capillary electrophoresis and next-generation sequencing (NGS), are useful for evaluating genetic variants, detecting biomarkers, and characterizing nucleic acids. As precision medicine gains traction in healthcare, demand for electrophoresis platforms that can facilitate genetic analysis and medication discovery is likely to rise, boosting market growth. Thus, driving the Electrophoresis market revenue.

Electrophoresis Market Segment Insights

• 
  

  Electrophoresis Product Insights

  
  

The Electrophoresis Market segmentation, based on Product, includes Electrophoresis Reagents, Electrophoresis Systems, Gel Documentation Systems, and Electrophoresis Software. In 2023, electrophoresis systems will be the largest segment of the market. This supremacy is partly due to constant technological developments in electrophoresis devices, which result in increased efficiency, accuracy, and automation in biomolecule separation and analysis. Furthermore, increasing demand for electrophoresis systems in research, diagnostic, and pharmaceutical applications drives market expansion.

• 
  

  Electrophoresis Application Insights

  
  

The Electrophoresis Market segmentation, based on Application, includes Research Applications, Diagnostic Applications, and Quality Control & Process Validation. In 2023, the largest sector of the market is research applications. This dominance can be ascribed to several reasons driving market expansion, including the expanded scope of proteomics and genomics research, increased investments in life sciences R&D, and growing collaborations between academic institutions and pharmaceutical firms. Researchers widely use electrophoresis techniques in a variety of domains to examine biomolecules, analyze gene expression patterns, sequence DNA, and characterize proteins.

Figure 1: Electrophoresis Market, by Application, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Electrophoresis End User Insights

The Electrophoresis Market segmentation, based on end users, includes Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, and Other End Users. In 2023, pharmaceutical and biotechnology companies accounted for the highest share of the market. This dominance is primarily driven by numerous reasons that contribute to market growth, including rising demand for improved analytical techniques for drug development, a growing emphasis on personalized medicine, and an expanding biopharmaceutical pipeline. Electrophoresis techniques are widely used in pharmaceutical and biotechnology industries for a variety of purposes, including protein analysis, nucleic acid separation, and quality control testing throughout manufacture.

Electrophoresis Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominates the electrophoresis market due to significant investments in R&D, a strong pharmaceutical and biotechnology industry, and modern healthcare infrastructure. Furthermore, the region's dominance in the market is strengthened by the presence of significant industry players and technological developments.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.

Figure 2: Electrophoresis Market Share By Region 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Electrophoresis market accounts for the second-largest market share. The region's expansion is being driven by increased government financing for life sciences research, an increase in the prevalence of chronic diseases, and a greater awareness of personalized medicine. Furthermore, strategic cooperation between academic institutions, research organizations, and healthcare sectors is driving the implementation of electrophoresis technology throughout Europe. Further, the German Electrophoresis market held the largest market share, and the UK Electrophoresis market was the fastest-growing market in the European region.

The Asia-Pacific Electrophoresis Market is expected to grow at the fastest CAGR from 2024 to 2032. Factors driving this growth include the rapid expansion of the pharmaceutical and biotechnology sectors, increased investments in healthcare infrastructure, and a greater emphasis on R&D. Furthermore, increased healthcare expenditure, combined with a high patient population in countries such as China and India, boosts demand for improved diagnostic techniques such as electrophoresis, fueling regional market expansion. Furthermore, favorable government efforts and alliances with international firms help to fuel the Asia-Pacific electrophoresis market's rapid growth. Moreover, China’s Electrophoresis market held the largest market share, and the Indian Electrophoresis market was the fastest-growing market in the Asia-Pacific region.

Electrophoresis Key Market Players & Competitive Insights

Competition in the electrophoresis business is fierce, with Leading market players vying for market share by launching new products, partnering, and buying out other companies. Market participants are undertaking market developments, including concentrating on developing revolutionary electrophoresis systems with greater functions, such as higher throughput, better resolution, and automated features, to meet the changing needs of researchers and diagnostic laboratories. Initiatives to expand geographical presence through distributor agreements and entry into new regions help to increase Electrophoresis industry competitiveness.

Furthermore, the industry is seeing major investments in R&D activities targeted at bringing new electrophoresis reagents and consumables to supplement existing systems in the global Electrophoresis industry. Major players in the Electrophoresis market, including Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. Inc. (US), QIAGEN N.V. (Netherlands), Lonza (Switzerland), Shimadzu Corporation (Japan), and HOEFER INC.(US).

Bio-Rad Laboratories, Inc., is a global leader in life science research and clinical diagnostics, providing a diverse variety of products and solutions to scientists, healthcare professionals, and researchers worldwide. Founded in 1952, Bio-Rad has a long history of invention and experience in fields like electrophoresis, PCR, imaging, and chromatography. The company's product offerings include laboratory instruments, reagents, consumables, software, and services for molecular biology research, protein analysis, and clinical diagnostics.

Danaher Corporation is a multinational conglomerate that focuses on life sciences, diagnostics, and environmental and applied solutions. Danaher, founded in 1969, has evolved into a global leader recognized for its diverse portfolio of innovative products and solutions. The company's life sciences section includes businesses that provide research tools, analytical instruments, and consumables to customers in biopharmaceuticals, academia, and healthcare. Danaher provides a broad range of diagnostic tools, reagents, and software solutions to clinical laboratories worldwide.

Key Companies in the Electrophoresis market include

• Bio-Rad Laboratories, Inc. (US)


• Thermo Fisher Scientific Inc. (US)


• Danaher Corporation (US),


• Merck KGaA (Germany)


• Agilent Technologies Inc. (US)


• PerkinElmer Inc. Inc. (US)


• QIAGEN N.V (Netherlands)


• Lonza (Switzerland)


• Shimadzu Corporation (Japan)


• HOEFER INC.(US)

Electrophoresis Industry Developments

September 2020: miniPCR Bio, a maker of scientific products for educators and researchers, announced the debut of the GELATO™ integrated DNA analysis device. GELATO™ combines gel electrophoresis with transillumination technology to separate and visualize nucleic acids in a single, compact instrument.

September 2020: Hitachi High-Tech Corporation announced today that the Hitachi DS3000 small capillary electrophoresis (CE) sequencer would be available for purchase through local agencies in Japan, China, South Korea, and Taiwan.

Electrophoresis Market Segmentation

Electrophoresis Product Outlook

• Electrophoresis Reagents


• Electrophoresis Systems


• Gel Documentation Systems


• Electrophoresis Software

Electrophoresis Application Outlook

• Research Applications


• Diagnostic Applications


• Quality Control & Process Validation

Electrophoresis End User Outlook

• Academic & Research Institutes


• Pharmaceutical & Biotechnology Companies


• Hospitals & Diagnostic Centers

Electrophoresis Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America